BUTRANS

This brand name is authorized in United States. It is also authorized in Canada, Germany, Ireland, Israel, Netherlands, Tunisia, UK.

Active ingredients

The drug BUTRANS contains one active pharmaceutical ingredient (API):

1	Buprenorphine UNII 40D3SCR4GZ - BUPRENORPHINE
	Buprenorphine is an opioid partial agonist/antagonist which attaches itself to the μ (mu) and κ (kappa) receptors of the brain. Its activity in opioid maintenance treatment is attributed to its slowly reversible link with the μ receptors which, over a prolonged period, minimises the need of illicit opioids for patients with opioid dependence.
	Read more about Buprenorphine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BUTRANS Transdermal system	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02AE01	Buprenorphine	N Nervous system → N02 Analgesics → N02A Opioids → N02AE Oripavine derivatives
Discover more medicines within N02AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02341174, 02341212, 02341220, 02450771
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	16624458, 16624464, 16624470
GB	Medicines & Healthcare Products Regulatory Agency	167349, 318773, 381241, 381243, 95657, 95660
IE	Health Products Regulatory Authority	14603, 14628, 14685, 23654
IL	מִשְׂרַד הַבְּרִיאוּת	6616, 6617, 6618, 8258
NL	Z-Index G-Standaard, PRK	89400, 89419, 89435
TN	Direction de la Pharmacie et du Médicament	1626301, 16263032, 16263033
US	FDA, National Drug Code	59011-750, 59011-751, 59011-752, 59011-757, 59011-758